Skip to content

QUALIBLOOD

Dissolution or liquidation
Public limited companyfounded 2017Rue Louvrex 55-57, 4000 Liège, BelgiumKBO/BCE: BE 0684.698.353
Summary

The KBO register records for QUALIBLOOD the legal situation: dissolution or liquidation; this is today's state according to the register itself, which carries no start date. The 2024 annual accounts show equity of €847,118 and a net result of -€560,095.

Watch Report
QUALIBLOODDissolution or liquidation
Report

Overview

What they do
Research and development on biotechnology
NACE 72101NACE 72110
1 site
How big
€2.6mtotal assets 2024
Staff
6.6 FTE
Equity
€847,118
Loss
-€560,095
Financially healthy?
Dissolution or liquidation: no score
Who decides
Accounts 63 d overdue0 of 7 deeds read
Signals- Register: dissolution or liquidationLatest accounts filed on timeShow the evidence

Signals

Two signals. The signal on the left, the evidence on the right.
+raises risk○neutral
raises risk · Register: dissolution or liquidation
The KBO register records the legal situation: dissolution or liquidation. This is today's state according to the register itself; the register carries no start date.
KBO · legal situation
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 07-05-2025, 85 days ahead of the deadline.
NBB · 7 filings
Deviation from the deadline
2025
not confirmed
2024
85 d early
2023
22 d early
2022
46 d early
2021
23 d late
2020
86 d early
2019
105 d early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 6 accounts on average 54 days before the deadline; the sector median for financial year 2024 is 13 days before the deadline, and 32% of the sector filed late.

Checked, nothing found (1)
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage
  1. Annual accounts filedfiscal year 2024 · full…
  2. Weakest financial yearnet -€560,095
  3. Equity above €500,000Eq €847,118 ▲354%

Key points

  • Risk: No longer activefounded 15-11-2017 Dissolution or liquidation View
  • Positive: Equity rose in 2024from €186,525 to €847,118 ▲ 354% View
  • Total assets 20246 fiscal years filed €2.6m View

By topic

Financials

Fiscal year
2024
Total assets
€2.6m
Loss
-€560,095
Solvency
32.3%
Total assets▲ 137%
Net result
20182024
Go to Financials

Timeline

Events
13
Since
2019
  1. 07-05-2025Annual accounts filed
  2. 31-12-2024Weakest financial year
  3. 31-12-2024Equity above €500,000
Go to Timeline

Company details

Sites
1
Legal form
Public limited company
Activity
Research and development on biotechnologyNACE 72101
Founded
15-11-2017
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Go further with this company

Who ran this company, and where was it based, on a date before the end?Company as of a date How is the Research and development on biotechnology sector doing?Sector figures

Investigating this company? Keep it with today's facts in a case file.

We would like to set cookies. That happens only with your consent. What we measure